Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Perfusion systems industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Technique trends
2.5 Component trends
2.6 Application trends
2.7 End-use trends
Chapter 3 Perfusion Systems Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
3.2.1.2 Rising number of organ transplantations
3.2.1.3 Increasing incidence of multiple organ failure among ageing population
3.2.1.4 Rising awareness regarding advance perfusion systems
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of perfusion systems
3.2.2.2 Ethical Concerns related to cell - based research
3.3 Growth potential analysis
3.3.1 By technique
3.3.2 By component
3.3.3 By application
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Perfusion Systems Market Size and Forecast, By Technique (USD Million)
5.1 Key trends, by technique
5.2 Hypothermic machine perfusion
5.3 Normothermic machine perfusion
Chapter 6 Perfusion Systems Market Size and Forecast, By Component (USD Million)
6.1 Key trends, by component
6.2 Oxygenators
6.3 Heart-lung machine
6.4 Perfusion pumps
6.5 Monitoring system
6.6 Bioreactor perfusion system
6.7 Others
Chapter 7 Perfusion Systems Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Cardiopulmonary perfusion system
7.3 Cell perfusion system
7.4 Ex-vivo organ perfusion system
Chapter 8 Perfusion Systems Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Others
Chapter 9 Perfusion Systems Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Sweden
9.3.7 Poland
9.3.8 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Thailand
9.4.8 Philippines
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.5.6 Peru
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Egypt
9.6.6 Turkey
Chapter 10 Company Profiles
10.1 ALA Scientific Instruments, Inc.
10.2 Bioptechs Inc.
10.3 Cytiva
10.4 Getinge AB
10.5 Harvard Bioscience, Inc.
10.6 Lifeline Scientific, Inc.
10.7 LivaNova
10.8 Medtronic, plc
10.9 Merck KGaA
10.10 Nipro Corporation
10.11 Repligen Corporation
10.12 Spectrum Laboratories, Inc.
10.13 Terumo Corporation
10.14 XENIOS AG
